Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Buy
3,895
+701
+22% +$25.2K 0.01% 1295
2026
Q1
$113K Buy
3,194
+1,627
+104% +$66.2K 0.01% 1252
2025
Q4
$63.6K Buy
1,567
+458
+41% +$19.9K 0.01% 1495
2025
Q3
$52.2K Buy
+1,109
New +$57.5K 0.01% 1561
2022
Q2
Sell
-975
Closed -$145K 1912
2022
Q1
$145K Buy
975
+60
+7% +$8.38K 0.07% 356
2021
Q4
$130K Sell
915
-31
-3% -$4.39K 0.06% 448
2021
Q3
$124K Buy
946
+238
+34% +$31.1K 0.08% 340
2021
Q2
$97K Buy
+708
New +$96.9K 0.06% 468

Other funds holding CNMD

State of Wyoming's CNMD Position: Q2 2026 in Review

State of Wyoming increased its CONMED (CNMD) stake by 22% in Q2 2026, buying an estimated $25.2K and bringing the position to 3,895 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #1295.

State of Wyoming first reported a position in CNMD in Q2 2021 and has held it in 8 quarters since. The position peaked at $145K in Q1 2022. 92 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • State of Wyoming held 3,895 shares of CONMED worth $127K as of Q2 2026.
  • State of Wyoming bought 701 CONMED shares in Q2 2026, an estimated $25.2K.
  • CONMED made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1295 holding.
  • State of Wyoming first reported a position in CONMED in Q2 2021 and has held it in 8 quarters since.
  • State of Wyoming's CONMED position peaked at $145K in Q1 2022.
  • 92 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.